<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have previously shown that <z:chebi fb="164" ids="18723">nicotine</z:chebi>, the addictive component of tobacco products, alters the blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) <z:chebi fb="0" ids="29101">Na(+)</z:chebi>,<z:chebi fb="0" ids="29103">K(+)</z:chebi>,2Cl(-) cotransporter (NKCC) during in vitro <z:mp ids='MP_0005039'>hypoxia</z:mp>-aglycemia exposure </plain></SENT>
<SENT sid="1" pm="."><plain>Attenuation of abluminal NKCC suggests that accumulation of ions in the brain extracellular fluid would result in an increase of fluid or cytotoxic <z:hpo ids='HP_0000969'>edema</z:hpo> in the brain during <z:mp ids='MP_0005039'>hypoxia</z:mp>-aglycemia or <z:hpo ids='HP_0001297'>stroke</z:hpo> conditions </plain></SENT>
<SENT sid="2" pm="."><plain>To further investigate whether <z:chebi fb="164" ids="18723">nicotine</z:chebi> products have the potential to worsen <z:hpo ids='HP_0001297'>stroke</z:hpo> outcome by increasing <z:hpo ids='HP_0000969'>edema</z:hpo> formation, two separate models to mimic <z:hpo ids='HP_0001297'>stroke</z:hpo> conditions were utilized to decipher the effects of short-term and long-term administrations of <z:chebi fb="164" ids="18723">nicotine</z:chebi> products on <z:hpo ids='HP_0002181'>brain edema</z:hpo> following <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Oxygen <z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation (OGD) was studied in rat hippocampal slices with short-term or long-term exposure to <z:chebi fb="164" ids="18723">nicotine</z:chebi> and cigarette smoke constituents </plain></SENT>
<SENT sid="4" pm="."><plain>During short-term exposure, the presence of <z:chebi fb="164" ids="18723">nicotine</z:chebi> at a concentration mimicking heavy smokers increased water content of hippocampal slices during OGD </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, long-term 1-week administration of <z:chebi fb="164" ids="18723">nicotine</z:chebi> increased water content in hippocampal slices that could be attenuated with <z:chebi fb="164" ids="18723">nicotine</z:chebi> <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> receptor (nAChR) <z:chebi fb="68" ids="48706">antagonists</z:chebi>, suggesting <z:chebi fb="164" ids="18723">nicotine</z:chebi> increase <z:hpo ids='HP_0000969'>edema</z:hpo> during OGD via nAChRs </plain></SENT>
<SENT sid="6" pm="."><plain>A second model of focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, showed an increase of <z:mpath ids='MPATH_124'>infarct</z:mpath> size during short-term exposure to <z:chebi fb="164" ids="18723">nicotine</z:chebi> and an increase of <z:hpo ids='HP_0000969'>edema</z:hpo> during both short-term and long-term administration of <z:chebi fb="164" ids="18723">nicotine</z:chebi>, compared with saline controls </plain></SENT>
<SENT sid="7" pm="."><plain>These findings support the paradigm that <z:chebi fb="164" ids="18723">nicotine</z:chebi> products not only increase the incidence of <z:hpo ids='HP_0001297'>stroke</z:hpo> but also have the potential to worsen <z:hpo ids='HP_0001297'>stroke</z:hpo> outcome by increased <z:hpo ids='HP_0000969'>edema</z:hpo> formation </plain></SENT>
</text></document>